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Purpose: The purpose of this study was to histologically and immuno-histochemically 
evaluate tissue changes in the maxillary sinus after bone screw implantation and 
maxillary sinus augmentation using self-setting α-tricalcium phosphate (α-TCP; 
BIOPEX®-R) in rabbit.  
Study design: Adult male Japanese white rabbits (n=15, 12-16 weeks, 2.5-3.0 kg) were 
used. The sinus lift was made from the nasal bone of a rabbit. The bone screws (Dual 
top auto-screw®) were implanted into the nasal bone, after BIOPEX®-R was implanted 
in the left elevated space (operated side) an atelocollagen sponge (ACS: Teruplug®) was 
implanted in the right elevated space (control side). The rabbits were sacrificed at 4, 12 
and 24 weeks postoperatively, and formalin-fixed specimens were embedded in acrylic 
resin. The specimens were stained with hematoxylin and eosin. For 
immune-histochemical analysis, the specimens were treated with bone morphogenetic 
protein-2 (BMP-2) antibodies. Finally, these were evaluated microscopically. 
Results: Tight bonding without fibrous tissue continued between the bone screw and 
BIOPEX®-R, and the rigidity of bone screw in the nasal bone kept for 24 weeks in all 
cases.  The area of new bone formation increased gradually on both sides, however 
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there was no significant difference between both sides at 4, 12 and 24 weeks. The 
number of BMP-2 stained cells on the experimental side was significantly larger than 
that on control side after 4 weeks (P=0.0361). 
Conclusion: This study suggested the usefulness of self-setting α-tricalcium phosphate 
(BIOPEX® -R) to keep the rigidity of implanted bone screws from an early period, and 
the result of BMP-2 expression suggested that BIOPEX® -R could have bone conductive 





Since, the maxillary sinus floor elevation was introduced by Taum and Boyne 
(Boyne & James 1980; Taum 1986), the use of autogenous bone grafts in sinus 
augmentation has been considered to be the “ gold standard” because of their excellent 
survival with loaded implants and the degree of functionality they afford (Kent & Block 
1989; Raghoebar 1993; Neukam 1994; Nishibori 1994). However, harvesting 
autogenous bone is generally associated with several limitations, including morbidity, 
infection, pain and blood loss.  To avoid the limitations associated with autogenous 
sources of bone, an array of alternatives, including allograft, xenograft and synthetic 
materials, has been explored. However, allografts and xenografts are susceptible to 
immunorejection and carry the risk of disease transmission (Moore et al. 2001; Simon et 
al. 2002; Ueda et al. 2005). Some synthetic materials have limited potential for 
osteoconduction. Using them alone has usually failed to achieve the bone volume 
expected (Wiltfang et al. 2002; Engelke et al. 2003). 
  Bovine hydroxyapatite is frequently used as grafting material in sinus lift procedures 
because of its specific surface that resembles that of cancellous bone, complete 
deproteinization of the inorganic component and thus absent antigenicity (Wetzel et al. 
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1995; Haaset al. 1998). β-TCP was one of the earliest calcium phosphate compounds to 
be used as a bone graft substitute due to its good osteoconductivity, biocompatibility, 
and sufficient mechanical stress. Especially, β-TCP was used as scaffold in combination 
with hyaluronic acid or bone marrow stromal cells in the sinus lift procedure (Schwarts 
et al. 2006; Jiang et al. 2009). 
On the other hand, Monma et al. (1988) have originally developed a self-setting 
cement-type calcium phosphate material consisting of α-TCP, dicalcium phosphate 
dibasic (DCPD) and tetracalcium phosphate monoxide (TeCP). According to their 
extensive studies, this cement-type material could be refined, demonstrating better 
biocompatibility and direct integration to bone without any participation of peripheral 
soft tissue (Kurashina et al. 1997a, 1997b; Kurashina et al. 1998; Yamamoto et al. 1998). 
As it is free of the infiltration with time of residual monomers of methacrylate resin, 
which has long been used for orthopedic treatment, this self-setting cement came to be 
rapidly highlighted for clinical use in Japan. In previous reports related to maxillary 
sinus augmentation, alternative granular types of materials were mainly used as scaffold.  
However, there was no report regarding the use of self-setting cement for the maxillary 
sinus lift procedure. 
  Therefore, an experimental study is necessary to assess the possibility of the use of 
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self-setting cement in the sinus lift surgery. 
The purpose of this study was to histologically and immuno-histochemically evaluate 
the change in surrounding bone screws and self-setting α-TCP after sinus augmentation 
surgery in rabbit. 
 
Materials and Methods 
 
The experimental protocol was approved by the Institutional Committee for 
Animal Care, Kanazawa University. Fifteen male Japanese white rabbits (12-16 weeks, 
2.5-3.0 kg) were used in this study.  
 
Surgical procedure 
 The entire procedure was performed under sterile conditions. First, the animals 
were anesthetized with sodium pentobarbital (25 mg/kg) by injection into the lateral ear 
vein. After the hair in the nasal region was shaved, 1.8 ml of 2% lidocaine containing 
1:80,000 epinephrine was administered to the surgical site. The surgical method by Asai 
et al. (2002) and Xu et al. (2003 and 2004) was modified and the operation was 
performed.  Both the nasal bone and nasoincisional suture line were exposed via a 
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perpendicular incision. With the use of a fissure bur, two nasal bone windows were 
outlined. A surgical defect (5mm diameter) was made with a fissure bur using continuous 
saline irrigation (Fig.1A).  The antral membrane was carefully stripped off posteriorly 
to make space for implantation of materials. The titanium bone screw (length 8 mm, 
diameter 2 mm, Dual top auto-screw® ,  Jeil Medical Co, Seoul, Korea) was implanted 
at 3 mm posteriorly from the surgical defect on each side （Fig. 1B and C).  
BIOPEX®-R (Pentax Co, Tokyo, Japan) was implanted in the left elevated space 
(operated side) (Fig.1 D) and 3×3×10 mm atelocollagen sponge (ACS: Teruplug®, 
Terumo Co, Tokyo, Japan ) was implanted in the right elevated space (control side) . 
After the rigidity of the implanted screw and self-setting of the implanted cement were 
recognized, a suture was placed between the periosterum and the skin. 
  
Histological examination 
The rabbits were sacrificed at 4, 12 and 24 weeks postoperatively and the 
specimens were collected for hematoxylin and eosin staining and also for 
immunno-histochemical analysis. After fixation with 10% phosphate-buffered formalin, 
the specimens with the titanium mesh were dehydrated in ethanol and technovit 
7200VCL (Kultzer and Co., GmbH, Wehreim, Germany) and then embedded in acrylic 
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resin. The embedded blocks were trimmed by a cutter and ground by abrasive paper. 
Thereafter, the sections were further ground to a final thickness of about 30 μm. Finally, 
the specimens were stained with hematoxylin and eosin and examined under the 
microscope. The region of implanted bone screw surface and the region of antral 
membrane were mainly observed (Fig. 2A).  The measurement area was located 
between the lateral surface of the implanted screw and the elevated antral membrane 
(Fig.2B). The new bone and BIOPEX®-R areas were measured with an image software 
(Image-Pro®, Media cybernetics, Silver Spring, MD,USA) and then the ratio of new 
bone formation (%) was calculated.  
The prepared sections were deacrylated in 2-methoxyethyl acetate, inhibited by 
endogenous peroxidase with 0.3% hydrogen peroxide and blocked in 10% normal 
serum prior to staining. For immunostaining, commercially available monoclonal 
anti-BMP-2 antibodies (Dako North America, Inc, CA, USA) were used. Sections were 
incubated overnight with these primary antibodies at 4ºC in a humidified chamber. A 
biotinylated goat anti-mouse IgG antibody (Wako Junyaku Inc., Osaka, Japan) was used 
as the secondary antibody. The Vectastain-Elite ABC kit detection system, DAB 
revelation kit and DAB enhancing solution (Wako Junyaku Inc., Osaka, Japan) were 
used to complete the immunostaining. Finally, a light Meyer’s hematoxylin counter 
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stain was applied. The sections were then dehydrated in alcohol and mounted for light 
microscopy to count the number of positively stained active cells in the regeneration site. 
The observation area located between the elevated antral membrane and BIOPEX®-R 
far from the implanted screw (Fig.2B). BMP-2 labeling index (%) was determined as 
the number of BMP-2 stained cells per voluntary 1000 cells in this area that were 
counted by hand using a high magnification photomicrograph (×400). 
 
Statistical Analysis  
Data of all the implanted materials were statistically analyzed with Stat View 4.5 
(ABACUS Concepts, Inc., Berkeley, CA, USA). Differences between the groups were 
analyzed by Mann-Whitney U’s test. Kruskal –Wallis test was used for the comparisons 





Healing progressed uneventfully in all animals and no postoperative 
complications were noted during the 24-week observation period. After resting for 3-6 
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days postoperative, the animals could move and leap without any notable pain or 
limitation. 
 
Antral membrane region 
    
  After 4 weeks, fibrous tissue or cell components including osteoblasts were 
recognized on both the experimental and control sides. The area occupied by fibrous 
tissue on the control side seemed to be comparatively larger than that on the 
experimental side. New bone formation was barely recognized between the BIOPEX®-R 
and the antral membrane was accompanied by absorption of the BIOPEX®-R by 
osteoclasts on the experimental side but not on the control side (Fig.3). On the 
experimental side, new bone seemed to have been derived not only from the mother 
bone of the nasal bone, but also the antral membrane. 
  After 12 weeks, fibrous tissue was found on both the experimental and control sides. 
Although the elevated space on the control side decreased, that on the experimental side 
was maintained.  New bone formation was first found on the control side. On the 
experimental side, absorption of surrounding BIOPEX®-R derived from osteoclasts was 
observed. New bone was also observed in the pores of BIOPEX®-R. (Fig. 4 and 5). 
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Fibrous tissue between new bone and BIOPEX®-R was not found at all. New bone 
seems to have been derived from only the mother bone of nasal bone on the control 
side. 
 After 24 weeks, new bone formation increased gradually on both sides. On the 
experimental side, absorption of BIOPEX®-R also increased (Fig. 6).  
 
Implanted bone screw region 
 
  After 4 weeks, fibrous tissue or cell components including osteoblasts were 
recognized on the control side. However, on the experimental side, fibrous tissue was 
not observed and complete bonding between the bone screw surface and BIOPEX was 
established.   
  After 12 weeks, fibrous tissue was found on the control sides. New bone formation 
was first seen on the control side.  On the experimental side, absorption of surrounding 
BIOPEX®-R was not observed and complete bonding between the bone screw surface 
and BIOPEX®-R remained tight. 
After 24 weeks, new bone formation increased gradually on the control side. On the 
experimental side, absorption of BIOPEX®-R was not found and few new bone 
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formation areas were observed at the region a little far from the bone screw in the pores 
of BIOPEX®-R. The bonding between the bone screw surface and BIOPEX®-R 
remained tight and bonding between the replaced new bone and screw was partially 
observed (Fig. 7).  
 
New bone area 
 
  There were no significant differences between the experimental side and control 
side in the rate of new bone area after 4, 12 and 24 weeks. On both sides, there were 
significant differences at 4, 12 and 24 weeks in the rate of new bone area ( the 
experimental side, 4 vs 12 weeks: P=0.0090, 4 vs 24 weeks: P=0.0090, 12 va 24 weeks: 
P=0.0474)( control side, 4 vs 12 weeks: P=0.0090, 4 vs 24 weeks: P=0.0090, 12 va 24 
weeks: P=0.0090) and new bone increased time-dependently (the experimental side: 
P=0.0037, control side: P=0.0019)(Fig. 8, Table 1). 
 
 
BMP-2 labeling index 
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The BMP-2 labeling index after 24 weeks was significantly larger than that after 12 
weeks on the control side (P=0.0361), but the time-course change was not significant in 
the experimental side. The BMP-2 labeling index on the experimental side was 
significantly larger than that on the control side after 4 (P=0.0361). However there was 




  Some models for maxillary sinus elevation using rabbits have been reported and 
they have played an important role to understand the histological change after the 
surgery for the use of various grafted materials. As air pressure causes movement of the 
maxillary sinus membrane, the grafted material in the sinus is subjected continuously to 
this air pressure, which will ultimately affect the augmented bone healing process and 
structure (Garey et al. 1991; Asai et al. 2002). In the study of Sun et al.(2007), both the 
group that used a tissue engineered bMSCs (bone marrow stromal cells) with 
OsteoBone® and the group that used OsteoBone® alone showed a convex segmented 
space, which suggested that the grafted material can withstand sinus air pressure and 
maintain the augmented space. Both groups showed increased bone area. Lamellar bone 
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structure in histological sections was observed at 8 weeks after surgery. Jiang et al. 
(2009) concluded that bMSCs modified with the AdBMP-2 (Adenovirus with BMP-2) 
gene can promote new bone formation and maturation in the rabbit maxillary sinus.  
     To achieve osseous healing, a grafted material needs to serve as a scaffold for 
the migration, attachment, and subsequent differentiation of osteoprogenitor cells from 
the recipient bed (Burchardt 1983; Yang et al. 1996). Various types of biocompatible 
graft materials have been developed in consideration of bone regeneration and 
augmentation as well as further procedures such as dental implantation (Simon et al. 
1994; Becker et al. 1996; Piatteli et al. 1997).  Autogenous bone graft has drawbacks 
such as the requirement of a second operation, which is sometimes accompanied by 
broad invasion, and a restricted source of materials. Alloplastic materials composed of 
inorganic substances such as tricalcium phosphate (TCP) or hydroxyapatite show 
biocompatibility and osteoconductivity (Leadley et al. 1991; Hollinger et al. 1996), 
which are the major reasons why this type of material has been widely employed for 
hard tissue repair (Oreamuno et al. 1990; Steven et al. 1991; Guillemin et al. 1993).  
 In the study of Jiang et al. (2009), the augmented space in all groups using β-TCP as 
scaffold showed a convex shape, and the statistical results proved that these groups 
maintained their augmented height over 8 weeks in the rabbit model. In our previous 
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study on onlay graft using rabbit mandible (Alam et al. 2007), in the 
immuno-histochemical examination after treatment with BMP-2 antibody, when the 
autologous group was compared with the control and β-TCP groups, the cell numbers 
increased significantly, and there was no significant difference between the control and 
β-TCP in terms of cell number at 2, 4 and 8 weeks. This suggested that bone inductive 
activity of β-TCP could be low. However, the β-TCP still remained and kept the 
volume at 8 weeks postoperative. There was also a clinical study that showed slow 
degradation of β-TCP in sinus augmentation (Zijderveld et al. 2005). However, in still 
other sinus elevation studies, faster absorption was reported using β-TCP (Horch et al. 
2006), which might indicate delayed oral function restoration for dental implants. 
Different findings from these studies might suggest differences between animal models 
and humans, or differences in the methods. 
α-TCP is predominant during bone resorption in the early stage of bone healing 
(Rajda et al. 1977; Nery et al. 1978; Nagase et al. 1989; Wada et al. 1989); this may lead 
to technical difficulties in both the filling of particles to fit the bone defects and their 
delivery to form the desired shape (Desjarding 1985; Propper 1985; Wittkampf 1988; 
Wittkampf 1989; Mirtchi et al. 1990). In the study of Yuan et al. (2000), they found that 
porous β-TCP ceramic could induce bone formation in soft tissue in dogs, but porous 
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α-TCP ceramic could not. They concluded that no bone formation in α-TCP might have 
resulted from its higher resorbability or more accurately, due to its rapid dissolution.  
The rapid dissolution of α-TCP also affected its cell-mediated resorption. However, 
cement type calcium phosphate material in paste form processes self-setting property in 
situ, thereby solving these technical problems (Mirtchi et al. 1991; Koshino et al. 1995; 
Miyamoto et al. 1995, 1997). The characteristic properties of the self setting materials 
work to prevent intervention for undesirable connective tissues or dispersion of the 
calcium phosphate particles in to the surrounding tissues. A cement-type calcium 
phosphate material with a self-setting property could be accurately fit on the surface of 
bone defects (Kent et al. 1983; Munting et al. 1993; Comuzzi et al. 2002), as was made 
evident by the study. This is further supported by a previous study using contact 
radiomicrogram where the tight attachment between rabbit bone surfaces and this 
material provided proof that BIOPEX® is inert in tissue fluid and maintains its strength 
in vivo for long periods (Kurashina et al. 1997; Kurashina et al. 1998). In the study of 
Hao et al. (2004) using rabbit femoral cortical bone, a range of osteoclasts accumulated 
on the surface of the BIOPEX®, whilst many osteoblasts were localized on the surface 
opposing the BIOPEX® from days 5 to 10. However, remnants of the BIOPEX® 
particles were present in the new born with a profile of compact bone on days 30 and 40. 
 17
The BIOPEX® was so hard that the osteoclasts could not resorb rapidly.  
     In this study, the absorption and bone formation of BIOPEX® was clearly 
observed at the region of the antral membrane after 12 weeks. However, complete 
bonding between the bone screw surface and BIOPEX® kept and no fibrous tissue could 
be seen even at 24 weeks postoperative. This suggested that bone formation and 
absorption of BIOPEX® could occur at the region close to the antral membrane and 
mother bone, but it could not occur at the contact surface between the screw and 
BIOPEX, because no cell component is present. In other words, bone replacement of 
BIOPEX could begin slowly from the contact surface to the antral membrane. The 
number of BMP-2 stained cell in the experimental side was significantly larger than that 
in the control side after 4 weeks. This suggested that BIOPEX® could have bone 
formation activity from an early stage after surgery. The relatively slow deposition of 
bone matrices appears to induce adequate bone formation temporarily in parallel to 
physiological mineralization speed, which results in compact bone rather than immature 
woven bone. This appears important for building new bone with sufficient strength and 
rigidity (Hao et al. 2004). However, it was not known whether the BIOPEX® could 
replace new bone tissue completely. Therefore, further examination and long time 
follow-up are needed.  
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   On the other hand, Comuzzi et al. (2001) stated that injectable calcium phosphate 
cement showed excellent clinical handling property combined with superior bone 
behavior and the degradation rate was very slow in the femoral bone of the goat. 
Therefore, they concluded that this current characteristic could hamper the final clinical 
applicability of the material as gap filler for peri-implant. In both of their studies and 
our current study, the finding that surrounding cement of the implanted screw replaced 
new bone completely was not recognized because of short follow-up period. When 
granules of bone substitute or cancellous bone are used in sinus augmentation, the 
fixture implanted in a thin posterior maxillary alveolar bone cannot bear occlusion in 
the early period. In this study, there was no fibrous tissue between the bone screw 
surface and BIOPEX® -R, the BIOPEX® -R was directly replaced by new compact bone, 
keeping the tight bonding to the screw surface. Therefore, bone formation in slow 
construction, rather than prompt bone formation, appears to provide a rigid bone 
suitable for implantation.  
In conclusion, this study suggested the usefulness of self-setting α-tricalcium 
phosphate (BIOPEX® -R) to keep the rigidity of implanted bone screws from an early 
period, and the resultant BMP-2 expression suggested that BIOPEX® -R could have 
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FIGURE 1.  (A) Bone defect at the nasal region from the superior view. (B) 
Surgically–created bone defects and implanted bone screws.  
(C) Bone screw (Dual top auto-screw®, Jeil Medical Co, Seoul, Korea).  (D) 
Self-setting α-TCP (BIOPEX®-R, Pentax Co, Tokyo, Japan). 
 
FIGURE 2.  (A) Schematic drawing of an implanted screw and BIOPEX®-R. New 
bone was measured in the blue colored part, (B) Whole histological image of the 
implanted screw and BIOPEX®-R (HE staining). Histological findings were observed in 
the black squares. N; Nasal cavity. S; Sinus cavity. Se; Nasal septum.BI; BIOPEX®-R 
 
FIGURE 3.  Photomicrographs after 4 weeks. (A) Experimental side (HE staining, 
original magnification × 40), (B) Experimental side (BMP-2 staining, original 
magnification ×400), (C) Control side (HE staining, original magnification ×40), (D) 
Control side (BMP-2 staining, original magnification ×40), N: Nasal cavity, Se: 
Septum, I : Implanted screw, Bi: BIOPEX-R, F: Fibrous tissue, Nb: Newly formed bone, 




FIGURE 4.  Photomicrographs after 12 weeks. (A) Experimental side (HE staining, 
original magnification × 40), (B) Experimental side (BMP-2 staining, original 
magnification ×400), (C) Control side (HE staining, original magnification ×40), (D) 
Control side (BMP-2 staining, original magnification ×40), N: Nasal cavity, Se: 
Septum, I : Implanted screw, Bi: BIOPEX-R, F: Fibrous tissue, Nb: Newly formed bone, 
P: Positive stained cells. Black bur shows 200 µm. 
 
FIGURE 5. Photomicrographs of experimental side after 12 weeks. (A) HE staining, 
original magnification ×100, (B) HE staining, original magnification ×400. Bi: 
BIOPEX-R, Nb: Newly formed bone, M:Antral membrane. 
 
FIGURE 6.  Photomicrographs after 4 weeks. (A) Experimental side (HE staining, 
original magnification × 40), (B) Experimental side (BMP-2 staining, original 
magnification ×40), (C) Control side (HE staining, original magnification ×40), (D) 
Control side (BMP-2 staining, original magnification ×400), N: Nasal cavity, Se: 
Septum, I : Implanted screw, Bi: BIOPEX-R, F: Fibrous tissue, Nb: Newly formed bone, 
P: Positive stained cells. Black bur shows 200 µm. 
 30
 
FIGURE 7. Photomicrographs of experimental side after 24 weeks. HE staining, 
original magnification ×100, Bi: BIOPEX-R, Nb: Newly formed bone, I; Implanted 
screw. 
 
FIGURE 8.  The ratio of new bone area.  * and ** indicate a significant difference at 
P<0.05. 
 
FIGURE 9.  BMP-2 labeling index.  * and ** indicate significant difference at 
P<0.05. 
 
Table 1. The ratio of new bone area. Bold number indicates median. 
 
















































































































































































Biopex control Biopex control Biopex control
max.
min.
Table 2
33.8
28.6
15.1
8.7
4.7
29.9
24.5
11.0
6.6
3.2
30.1
18.6
8.8
7.1
4.4
8.7
5.6
3.4
2.2
2.1
13.0
9.8
7.7
5.5
4.2
31.0
29.3
23.1
13.2
11.6
